Psychiatry Month in Review: April 2024
This month in review features top psychiatry news in the pipeline, FDA approvals, and a piece for autism awareness month.
Source: hcplive.com
Stay updated with breaking news from Cenexcel Research. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
This month in review features top psychiatry news in the pipeline, FDA approvals, and a piece for autism awareness month.
In an interview, Larry Ereshefsky, PharmD, discussed other conditions brilaroxazine could potentially treat other than schizophrenia due to its mechanism.
Larry Ereshefsky, PharmD, discussed the effects of brilaroxazine on inflammatory cytokines and neuroinflammation and how this can impact future schizophrenia treatment.